# Assessing Gonadotropin-Releasing Hormone Agonists Benefit in Preserving the Ovarian Function in Premenopausal Breast Cancer Patients During Chemotherapy

> **NCT07127315** · — · COMPLETED · sponsor: **Helwan University** · enrollment: 100 (actual)

## Conditions studied

- Gonadotropin Releasing Hormone Agonists
- Ovarian Function
- Premenopausal
- Breast Cancer
- Chemotherapy

## Interventions

- **DRUG:** Gonadotropin-releasing hormone agonist
- **DRUG:** Chemotherapy

## Key facts

- **NCT ID:** NCT07127315
- **Lead sponsor:** Helwan University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-01
- **Primary completion:** 2024-06-01
- **Final completion:** 2024-07-01
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2025-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07127315

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07127315, "Assessing Gonadotropin-Releasing Hormone Agonists Benefit in Preserving the Ovarian Function in Premenopausal Breast Cancer Patients During Chemotherapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07127315. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*